Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg
Ahmedabad, India, 24 July, 2025 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received tentative approval from the United States Food and Drug Administration (USFDA) […]
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg
Ahmedabad, India | July 15, 2025 Zydus Lifesciences Limited (including its subsidiaries and affiliates, hereafter referred to as “Zydus”) has received final approval from the U.S. Food and Drug Administration (USFDA) to […]
Zydus Lifesciences’ ‘Easiest Exam’ Campaign a Public Health Initiative in Breast Cancer Awareness reaches millions, wins accolades
Campaign empowers women to prioritise their health through thought provoking films, influencer-led campaigns, Scientific and medical podcasts, survivor experiences, and digital awareness National, India, May 26, 2025 Zydus Lifesciences’ nationwide […]